L7 PLM
One governed record for lifecycle CMC development, whether you're a Pharma or Biotech sponsor working with many CRDMOs or a CRDMO serving many sponsors.
Your PPM tool plans the portfolio. L7 PLM governs the execution underneath it.
L7 PLM is a collaborative application on L7|ESP® that connects Pharma and Biotech CMC development teams with their CRDMO partners, in both directions. Sponsors govern every CRDMO relationship in one record, and CRDMOs do the same across every sponsor they serve. Teams get one governed place to create, find, and manage the documents behind every project, across the entire portfolio. Working with L7 MES, L7 LIMS, and L7 Notebooks, L7 PLM accelerates tech transfer and carries each molecule through its lifecycle stage gates, from early phase to late phase.
To bridge the gap between unstructured files and actionable intelligence, L7 PLM can use L7|SYNAPSE™ to take executed batch records, certificates of testing, and stability study reports and convert this document-centric data into structured, submission-ready datasets. Every document, campaign batch, stability study, and partner upload is linked in L7|ESP’s relationship graph. A program leader can trace a result back to its study, its batch, and the CRDMO that submitted it, while partners have clear, scoped visibility into what is required.
When a CRDMO misses a stability pull, the sponsor finds out late.
CMC development programs run on collaborative work from many hands: internal scientists at Pharma and Biotech organizations, alongside their external CRDMO partners. The evidence behind each milestone often ends up scattered across inboxes, shared drives, and general-purpose apps. Without a reliable bi-directional flow of information, when a CRDMO misses a stability pull, the sponsor finds out late and chases it by hand. Program leaders spend their time reconstructing status instead of acting on it, and the legacy PLM systems that once held this together are reaching end of life.
Traceability starts with a single governed, bi-directional record.
L7 PLM builds it layer by layer on L7|ESP, so every result can be traced back to its batch, its study, and the CRDMO that submitted it.
L7 PLM builds it layer by layer on L7|ESP, so every result can be traced back to its batch, its study, and the CRDMO that submitted it.
What changes with L7 PLM.
Less than 1 min
to create a full stability study with every pull scheduled.
Portfolio-wide traceability
to track every molecule and asset across early phase to late phase development.
Structured data generation
to transform raw, document-centric partner deliverables into submission-ready datasets via L7|SYNAPSE.
Every version
records who published it, when, and why, and locks once published.
Every pull
carries an audit-ready status, with bi-directional reminders that escalate to QA.
Every result
traces back to its batch, its study, and the CRDMO partner that submitted it.
Built for regulated collaboration.
21 CFR Part 11 e-signatures.
Complete audit trail of who, when, and why, including study cancellations.
Complete audit trail of who, when, and why, including study cancellations.
Proven in a regulated enterprise.
L7 PLM went live at a global pharmaceutical company, initially replacing an end-of-life PLM system for early-phase development. The rollout spanned four organizations and passed enterprise cybersecurity, privacy, and identity reviews, including MFA access for external CRDMO users.
L7 PLM replaced our legacy PLM for creating, finding, and managing early-phase documents, and is meant to eventually connect into a knowledge layer for AI use cases.
Dive deeper into the platform.
L7 PLM Datasheet
L7 PLM is a collaborative application on L7|ESP® that connects Pharma and Biotech CMC development teams with their CRDMO partners in one governed, bi-directional record. Designed for regulated CRDMO collaboration, it links documents, batches, stability studies, and partner uploads so every result traces back to its source. This datasheet provides an introduction to L7 PLM…
DownloadL7|ESP® Platform Brochure
L7|ESP® is the Agentic Operating System for Precision Science, bringing workflow orchestration, data contextualization, scientific applications, and system connectivity into one operating environment. It supports research, development, manufacturing, quality, and diagnostics while preserving the relationships among processes, materials, instruments, people, and results as work is executed. This brochure provides an overview of the L7|ESP architecture,…
DownloadL7|SYNAPSE™ Datasheet
L7|SYNAPSE™ is the agentic AI layer of L7|ESP®, connecting natural-language interaction with governed scientific data, approved documentation, user permissions, and workflow execution. Designed for regulated life sciences environments, it grounds responses in an organization’s own knowledge and operational context. This datasheet provides an introduction to L7|SYNAPSE and its capabilities for retrieving information across L7|ESP, generating…
DownloadL7 MES Datasheet
L7 MES is the manufacturing execution system application within L7|ESP® for regulated pharmaceutical and advanced therapeutics production. It manages master batch records, electronic batch records, recipes, materials, samples, specifications, signatures, deviations, and quality review within connected manufacturing workflows. The datasheet introduces capabilities for dynamic process execution, conditional routing, review by exception, batch reporting, sample coordination…
DownloadL7 LIMS Datasheet
L7 LIMS is the laboratory information management application within L7|ESP®. It manages samples, tests, results, protocols, laboratory resources, and supporting records in the same environment used to orchestrate scientific workflows and contextualize data across research, development, quality control, and diagnostic operations. The datasheet introduces L7 LIMS capabilities for sample lifecycle tracking, workflow execution, SOP enforcement,…
DownloadCMC-in-the-Loop
AI is accelerating discovery faster than CMC can keep up, and the work now spans a network of external partners. This white paper from L7 Informatics CEO Vasu Rangadass makes the case for CMC-in-the-Loop: coordinating molecules across internal labs and CDMOs on one governed data model, from research through technology transfer.
DownloadBeyond Lab-in-the-Loop: Orchestrating CMC-in-the-Loop
AI is accelerating drug discovery, but CMC has become the constraint that decides how fast candidates reach patients, and it now spans a network of external partners. Vasu Rangadass, CEO of L7 Informatics, explains how CMC-in-the-Loop coordinates that work across internal labs and CDMOs on one governed data model, so process knowledge and quality data…
Read